KalVista Pharmaceuticals, Inc. (KALV)

15.39 -0.44 (-2.78%) USD  |  NASDAQ  |  Feb 23, 13:07
More

KalVista Pharmaceuticals Price Target Std Dev

Price Target Std Dev Chart

View Price Target Std Dev for KALV.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price Target Std Dev Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Price Target Std Dev Range, Past 5 Years

View Price Target Std Dev Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price Target Std Dev Benchmarks

View Price Target Std Dev Benchmarks
Start Trial
BioCryst Pharmaceuticals, Inc. Upgrade
Modular Medical, Inc. Upgrade
Iovance Biotherapeutics, Inc. Upgrade
Plus Therapeutics, Inc. Upgrade
BioStem Technologies, Inc. Upgrade